Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat - Wikidata - awgldk - TriplyDB

Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat

Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat

http://www.wikidata.org/entity/Q34211840

about

Osteopontin is produced by rat cardiac fibroblasts and mediates A(II)-induced DNA synthesis and collagen gel contraction Drug-eluting stent: a review and update Nanoparticulate carriers for the treatment of coronary restenosis Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia Peroxisome proliferator-activated receptor-gamma agonists suppress tissue factor overexpression in rat balloon injury model with paclitaxel infusion ZIPK is critical for the motility and contractility of VSMCs through the regulation of nonmuscle myosin II isoforms.c-Jun regulates shear- and injury-inducible Egr-1 expression, vein graft stenosis after autologous end-to-side transplantation in rabbits, and intimal hyperplasia in human saphenous veins.Redox control of vascular smooth muscle migration.Novel approaches for the prevention of restenosis.Drug-eluting stents Promoting endothelial recovery and reducing neointimal hyperplasia using sequential-like release of acetylsalicylic acid and paclitaxel-loaded biodegradable stents Stent development and local drug delivery.Candidate genes and mechanisms for 2-methoxyestradiol-mediated vasoprotection.Stent-based antirestenotic coatings (sirolimus/paclitaxel).Paclitaxel induces thrombomodulin downregulation in human aortic endothelial cells.Targeting the cell cycle machinery for the treatment of cardiovascular disease.In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid-polymeric nanoparticles Clinical trials in restenosis with 7-hexanoyltaxol and paclitaxel-eluting stents.Sirolimus- or paclitaxel-eluting stents to prevent coronary artery restenosis.Drug-eluting stents: a mechanical and pharmacologic approach to coronary artery disease.Epothilones Suppress Neointimal Thickening in the Rat Carotid Balloon-Injury Model by Inducing Vascular Smooth Muscle Cell Apoptosis through p53-Dependent Signaling Pathway.Pharmacological treatment for prevention of restenosis.Proliferation, migration and invasion of human glioma cells exposed to paclitaxel (Taxol) in vitro.Paclitaxel interrupts TGF-beta1 signaling between gallbladder epithelial cells and myofibroblasts 2-Methoxyestradiol blocks the RhoA/ROCK1 pathway in human aortic smooth muscle cells Paclitaxel-coated balloon fistuloplasty versus plain balloon fistuloplasty only to preserve the patency of arteriovenous fistulae used for haemodialysis (PAVE): study protocol for a randomised controlled trial.Smooth Muscle Cell-targeted RNA Aptamer Inhibits Neointimal Formation.The safety of drug-eluting stents.Design and evaluation of a PEGylated lipopeptide equipped with drug-interactive motifs as an improved drug carrier.Nanoparticle drug- and gene-eluting stents for the prevention and treatment of coronary restenosis.Effect of Stents Coated with Artemisinin or Dihydroartemisinin in a Porcine Coronary Restenosis Model.Drug-eluting balloon: new tool in the box.Vascular smooth muscle cell proliferation in restenosis.Plumericin inhibits proliferation of vascular smooth muscle cells by blocking STAT3 signaling via S-glutathionylation.Local delivery of paclitaxel in the treatment of peripheral arterial disease.Intravascular Ultrasound-Derived Stent Dimensions as Predictors of Angiographic Restenosis Following Nitinol Stent Implantation in the Superficial Femoral Artery.Comparison of 12-month outcomes with zotarolimus- and Paclitaxel-eluting stents: a meta-analysis.An in silico study on the role of smooth muscle cell migration in neointimal formation after coronary stenting.Chronic allograft rejection: A significant hurdle to transplant success.Delivery of Antioxidant and Anti-inflammatory Agents for Tissue Engineered Vascular Grafts.

P2860

Q24561906-4FC7216D-98FB-4017-9B6D-40FDFD03E192 Q28219254-60E1E290-8FDF-4911-9F81-FE1A50E716BE Q28220309-E3C18D7B-6131-4D74-9828-01315067CB42 Q28379241-E507DDA7-38E8-468A-9FAE-1E084AEF69B6 Q28478187-E5AE2559-A62F-4F7C-BEE9-8810BF7374D7 Q33568853-AC4DA995-C3E4-4990-871B-A93F7E83773C Q33662275-D7C91E83-A1E8-491B-AD4C-5DCB7B0BB8CD Q33690103-1B4603B8-9B78-457F-B42D-2B4F4DD32514 Q34075160-2B8EA2AA-63C7-41B2-BC67-172EE68DC9AA Q34091036-EEB4C05D-B5A1-4041-9616-D150022A4920 Q34148996-0FDF738B-48EA-4451-8F6E-941A5AD2BC35 Q34470332-D9F62BF8-D076-4588-B2B9-5BB097E97E8C Q34502795-99DE64E4-6518-48D8-B1CE-3AB5A1F63FEB Q34547687-8BADC78B-DBD8-4A6F-8549-DEB1C1B715D7 Q34698151-920DCB0A-768B-4B2E-8BEC-0E159A0A025B Q35164884-69E27453-F713-4A6E-83D1-872DE855D66D Q35585791-19016EAD-5415-4C7A-B095-0FFECDD298AC Q35879094-1B3A75A9-12C6-4488-9B50-EFC6FA1DB590 Q35925484-0685031F-5081-4EB5-A19D-F3AE9FAA7562 Q35945466-C36CCA22-8883-4B64-93C5-7FD1545C157F Q36027735-6E82E57A-DDE6-4C10-B69B-ACEADA37EF36 Q36179679-B55F0168-C16D-40A9-9043-374E024883F1 Q36421995-A5D8FD42-84EF-4BE2-B39E-B52C6BCE6446 Q36607944-9CA23792-B7AA-4CA2-AC8F-F3DA050C5F14 Q36751816-C7885A78-013B-49B7-A038-8460D3C55293 Q36899561-E30C9FD4-DA80-425F-BCA3-110A8FC05DC2 Q36951272-1A242C9D-7231-4CE1-A33E-E48CF55244AA Q37362714-89AA1412-B09B-42D7-A9E1-CAA7222A33FA Q37469417-F35A196C-A19A-4B70-8AB9-C85B2CC1C3F7 Q37511128-102693FB-0B18-48BB-8BF2-6DAF80B412C5 Q37619057-9E5C5E93-0357-4CF9-880C-684F0F7D1B86 Q37737338-E74C9B66-CD0C-4494-AF61-6654090ADBCA Q37843083-A09F8132-63E0-4401-9CD0-86477C9E8644 Q38302272-E1F5E58E-6F11-43D6-86EA-9B4134B6B3DE Q38329893-FF3F8326-BF0A-4517-89C0-340AF5C6A000 Q38797956-6E44AA9D-C41F-46AA-8324-6FC8CE1043E7 Q40545165-D0A4DDE6-8603-49C9-83C9-9C3087755F0D Q40847236-60DD4D57-3788-42D2-BFE9-B7B1A7004022 Q41384637-373B4713-FD5B-4C9F-A6F4-86E7799B68D4 Q42369932-9A050885-B621-4707-93A4-F3E12F20EFB7

P2860

Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat

http://www.wikidata.org/entity/Q34211840

description

1995 nî lūn-bûn

@nan

1995 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

1995 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu

name

Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat

@ast

Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat

@en

Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat

@nl

type

label

Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat

@ast

Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat

@en

Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat

@nl

prefLabel

Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat

@ast

Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat

@en

Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat

@nl

P1433

Q34211840-47F520B9-C2FC-414B-BF76-A115AC9DC1BD

P1476

Q34211840-8F7B6E7A-F550-4D1E-952C-6B1205349ECF

P2093

Q34211840-1247F26F-EB05-4FDF-BA10-25FBC3E85EDE

Q34211840-25298412-34EB-4A15-AE8D-BCF33C3B7770

Q34211840-2C6C8BD7-0D62-47A9-A349-0DB6A839F01B

Q34211840-3D136B01-C863-4C63-9AE0-9314076FA5D7

Q34211840-5E6A4150-6628-488A-9B09-CBD07FE12D6C

Q34211840-8D3ABC9A-4FDF-49B3-BB75-A0C7EAF8488B

Q34211840-D219C5BC-C107-4465-B03E-540F93E0DD0B

Q34211840-D81BB683-2767-404B-BD07-5B5DE07C1618

Q34211840-EEEE78D4-5277-469F-B5A8-CCE459DE2785

Q34211840-FF6825B6-C47A-4228-A5E7-11D688CDC19E

P2860

Q34211840-0210CBF9-58AB-46EF-9A05-D9455962BC70

Q34211840-05918C9D-7D51-49A9-A0A1-814789E093BE

Q34211840-07D298FB-E0C3-4A58-993F-BBF59C7DAFCE

Q34211840-0EDB78CD-6EC7-4D4B-BA2D-03B7DAF4C70A

Q34211840-15E35C68-5AA7-42A3-9894-FC998DE016DB

Q34211840-19CDC6C5-C7B1-4B6E-A436-682E679861E1

Q34211840-1C67DC08-9EB4-4D3F-838A-80B3F71984BD

Q34211840-1F9D209C-73EB-4B1D-B435-22DEA8E4CD7C

Q34211840-25326AB4-E716-4023-B69B-7F7AFFAC953A

Q34211840-29E2AE91-D28F-4C45-89A9-7D62F69F7AC3

P304

Q34211840-61999CBD-4133-4EAF-98C6-4755B0044A2F

P31

Q34211840-6E49A5E6-24F1-4738-AB5C-F97E2E8FEF39

P356

Q34211840-552584CA-22FD-4676-A6BA-22459FDF2806

P407

Q34211840-F282D79A-11AA-4C56-8DCF-ED90AC21F2A0

P433

Q34211840-F6626199-69F6-4C19-BF87-79433821A785

P478

Q34211840-DBA9ED4E-8305-4FE0-BD73-4FFD035EF86F

P577

Q34211840-6B0E2DFA-8F18-4028-8D47-F846D72B1E7A

P698

Q34211840-D3A265D6-D584-4257-9466-3AA3A2930AAE

P932

Q34211840-347ECA3B-90FC-4DA4-B076-BDC1846735CB

P356

P1433

Journal of Clinical Investigation

P1476

Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat

@en

P2093

Cheng L

http://www.w3.org/2001/XMLSchema#string

Crow MT

http://www.w3.org/2001/XMLSchema#string

Froehlich JP

http://www.w3.org/2001/XMLSchema#string

Jenkins GM

http://www.w3.org/2001/XMLSchema#string

Kuzuya M

http://www.w3.org/2001/XMLSchema#string

Lakatta EG

http://www.w3.org/2001/XMLSchema#string

Monticone RE

http://www.w3.org/2001/XMLSchema#string

Pauly RR

http://www.w3.org/2001/XMLSchema#string

Rowinsky EK

http://www.w3.org/2001/XMLSchema#string

Sollott SJ

http://www.w3.org/2001/XMLSchema#string

P2860

Basement membrane complexes with biological activity

The pathogenesis of atherosclerosis: a perspective for the 1990s

Action of colchicine and heavy water on the polymerization of microtubules in wheat root meristem.

Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer.

The effect of thrombocytopenia on experimental arteriosclerotic lesion formation in rabbits. Smooth muscle cell proliferation and re-endothelialization.

Cell proliferation in human coronary arteries.

Cytoskeleton-disrupting drugs enhance effect of growth factors and hormones on initiation of DNA synthesis.

Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia.

Simian virus 40 large T antigen and p53 are microtubule-associated proteins in transformed cells.

Microtubule-disrupting agents affect two different events regulating the initiation of DNA synthesis in Swiss 3T3 cells.

P304

1869-1876

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI117867

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P577

1995-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

7706494

http://www.w3.org/2001/XMLSchema#string

P932

295730

http://www.w3.org/2001/XMLSchema#string